T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.19% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 10.74% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Synaptics
SYNA
$4.2B
| $60.9M | 0.01% |
305,083
+131,479
| +76% | +$29.2M |
|
|
AGNT
902
AGNT Inc
AGNT
$752M
| $60.5M | 0.01% |
2,858,570
+969,319
| +51% | +$25.4M |
|
903
GXO Logistics
GXO
$5.56B
| $60.3M | 0.01% |
845,402
+37,685
| +5% | +$3.01M |
|
904
Allstate
ALL
$65.9B
| $60.1M | 0.01% |
434,143
-25,914
| -6% | -$3.25M |
|
|
IGMS
905
DELISTED
IGM Biosciences
IGMS
| $60M | 0.01% |
2,246,041
-125,234
| -5% | -$2.33M |
|
|
ANSS
906
DELISTED
Ansys
ANSS
| $60M | 0.01% |
188,827
-18,945
| -9% | -$6.19M |
|
907
Inspire Medical Systems
INSP
$1.68B
| $60M | 0.01% |
233,591
+2,835
| +1% | +$648K |
|
908
Zscaler
ZS
$30.4B
| $59.7M | 0.01% |
247,523
+29,023
| +13% | +$7.13M |
|
909
Atkore
ATKR
$3.17B
| $59.6M | 0.01% |
605,026
+15
| +0% | +$1.56K |
|
910
Ryan Specialty Holdings
RYAN
$11B
| $59.5M | 0.01% |
1,533,075
-719
| -0% | -$27.3K |
|
|
HAYN
911
DELISTED
Haynes International, Inc.
HAYN
| $59.1M | 0.01% |
1,387,325
-5,402
| -0.4% | -$213K |
|
912
General Mills
GIS
$20.8B
| $58.9M | 0.01% |
870,302
-45,718
| -5% | -$3.07M |
|
913
Federal Realty Investment Trust
FRT
$10.3B
| $58.9M | 0.01% |
482,773
-36,566
| -7% | -$4.5M |
|
914
Williams Companies
WMB
$89.3B
| $58.9M | 0.01% |
1,761,438
-78,459
| -4% | -$2.4M |
|
915
Revolution Medicines
RVMD
$43.3B
| $58.7M | 0.01% |
2,299,816
+1,244,045
| +118% | +$27.1M |
|
|
DHR.PRB
916
DELISTED
Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B
DHR.PRB
| $58.6M | 0.01% |
37,263
-475
| -1% | -$725K |
|
917
Merit Medical Systems
MMSI
$5.4B
| $58.4M | 0.01% |
877,539
+11,375
| +1% | +$684K |
|
918
Phillips 66
PSX
$92.8B
| $58.1M | 0.01% |
672,277
+6,311
| +0.9% | +$531K |
|
|
SGI
919
Somnigroup International
SGI
$14B
| $58M | 0.01% |
2,076,514
-216,956
| -9% | -$7.99M |
|
|
AVLR
920
DELISTED
Avalara, Inc.
AVLR
| $58M | 0.01% |
582,559
-2,518,524
| -81% | -$255M |
|
921
Digital Realty Trust
DLR
$73.1B
| $57.9M | 0.01% |
408,620
-20,629
| -5% | -$2.98M |
|
922
Teradyne
TER
$64.2B
| $57.9M | 0.01% |
489,797
-41,608
| -8% | -$5.27M |
|
923
VanEck Gold Miners ETF
GDX
$26.9B
| $57.8M | 0.01% |
1,507,188
+127,500
| +9% | +$4.33M |
|
924
Texas Pacific Land
TPL
$23.9B
| $57.6M | 0.01% |
383,364
-205,497
| -35% | -$27.1M |
|
925
HP
HPQ
$28.6B
| $57M | 0.01% |
1,570,627
-187,874
| -11% | -$6.94M |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.